RESUMO
Objective To explore the influence of chronic disease long prescription management on the treatment effect of the patients with hypertension during the novel coronavirus pneumonia（COVID-19) epidemic period. Methods Eighty patients with hypertension chronic disease and with relatively stable condition, suitable for long medication and documented management in the outpatient department of a hospital from May 2020 to April 2021 were selected and randomly divided into the long term prescription treatment group and conventional treatment group, 40 cases in each group by using a simple randomized sampling method. The two groups conducted the standard management and 1-year follow up.The systolic blood pressure, diastolic blood pressure, body mass index (BMI),satisfaction rate, visit time and cumulative visit times were compared between the two groups, and then the blood pressure control rate was calculated. Results There were no statistically significant differences in the systolic and diastolic blood pressure, blood pressure control and BMI at the first time and final follow up between the two groups（P＞0.05）;the satisfaction rate of the patients in the long prescription treatment group was significantly higher than that in the routine treatment group（P＜0.05）,while the visiting time and cumulative visiting number in the long prescription treatment group were significantly lower than those in the routine treatment group, and the difference was statistically significant（P＜0.05）.Conclusion Compared with the conventional treatment method, the chronic disease long prescription will not have an impact on the treatment effect and safety in the patients with hypertension, but it could effectively shorten the visiting time of the patients, reduce the number of visits, effectively improve the satisfaction rate of the patients, help to improve the treatment compliance of the patients and promote the prognosis of the disease. (English) [ FROM AUTHOR] 目的 探索新型冠状病毒感染疫情防控期间慢病长处方管理对高血压患者疗效的影响. 方法 选取2020年5月至2021年4月在某院门诊就诊的病情相对稳定、适合长期服药, 并且已建档管理的高血压慢性病患者80例, 通过简单随机化抽样方法, 将抽样样本随机分为长处方治疗组和常规治疗组, 每组40例. 2组均规范管理, 随访1年. 比较2组患者收缩压、舒张压、体重指数、满意率、就诊时间和累积就诊次数, 计算血压控制率. 结果 2组患者首次及终末随访收缩压、舒张压、血压控制情况、体重指数比较, 差异均无统计学意义（P＞0.05）;长处方治疗组患者满意率明显高于常规治疗组, 就诊时间和累积就诊次数均明显低于常规治疗组, 差异均有统计学意义（P＜0.05) . 结论 与常规治疗方法比较, 慢病长处方不会对高血压患者疗效、安全性产生影响, 但能有效缩短患者就诊时间, 减少其就诊次数, 有效改善患者的满意度, 有助于提高患者治疗的依从性, 促进疾病转归. (Chinese) [ FROM AUTHOR] Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)